131 related articles for article (PubMed ID: 34677924)
1. Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?
Gizhlaryan M; Aghabekyan T; Arakelyan T; Petrosyan M; Iskanyan S; Tamamyan G; Sargsyan L; Papyan R
Oncology (Williston Park); 2021 Oct; 35(10):665-667. PubMed ID: 34677924
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
[TBL] [Abstract][Full Text] [Related]
3. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
[TBL] [Abstract][Full Text] [Related]
4. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
Bell J; Moran C; Blatt J
Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
[TBL] [Abstract][Full Text] [Related]
5. Dancing eyes, dancing feet: opsoclonus-myoclonus in an 18-month-old child with neuroblastoma.
Badaki OB; Schapiro ES
Pediatr Emerg Care; 2007 Dec; 23(12):885-8. PubMed ID: 18091597
[TBL] [Abstract][Full Text] [Related]
6. Dancing Eyes.
Kaur A; Bhagwat C; Madaan P; Saini L; Bhatia A; Singh H; Sankhyan N
J Pediatr; 2019 Nov; 214():231. PubMed ID: 31303334
[No Abstract] [Full Text] [Related]
7. Ophthalmic presentation in the emergency department: a case report of a girl with "shimmering eyes".
Krivochenitser R; Lemma Y; Wynn B; Jones JS
J Emerg Med; 2014 Jun; 46(6):e163-5. PubMed ID: 24698510
[TBL] [Abstract][Full Text] [Related]
8. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
9. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
[TBL] [Abstract][Full Text] [Related]
10. The opsoclonus–myoclonus syndrome.
Sahu JK; Prasad K
Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
[TBL] [Abstract][Full Text] [Related]
11. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
Gupta A; Kundal R; Pandey M
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
[TBL] [Abstract][Full Text] [Related]
12. Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.
Morales La Madrid A; Rubin CM; Kohrman M; Pytel P; Cohn SL
Pediatr Blood Cancer; 2012 Mar; 58(3):472-4. PubMed ID: 21480475
[TBL] [Abstract][Full Text] [Related]
13. Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
Ketterl TG; Messinger YH; Niess DR; Gilles E; Engel WK; Perkins JL
Pediatr Blood Cancer; 2013 Dec; 60(12):E163-5. PubMed ID: 23813921
[TBL] [Abstract][Full Text] [Related]
14. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
[TBL] [Abstract][Full Text] [Related]
15. [Whole-body magnetic resonance imaging in a patient with an occult abdominal neuroblastoma and opsoclonus-myoclonus syndrome].
Miras Azcón F; Culiañez Casas M; Pastor Pons E
Radiologia; 2014; 56(6):e54-7. PubMed ID: 22818898
[TBL] [Abstract][Full Text] [Related]
16. [A case report on cervical neuroblastoma with ataxia].
Kanemura N; Nakano T; Hirano A; Amatsu H; Koshimo N; Uemura G; Aiba T
Nihon Jibiinkoka Gakkai Kaiho; 2011 May; 114(5):505-10. PubMed ID: 21702171
[TBL] [Abstract][Full Text] [Related]
17. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
18. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
[TBL] [Abstract][Full Text] [Related]
19. Opsoclonus and neuroblastoma.
Davidson M; Tolentino Y; Sapir S
N Engl J Med; 1968 Oct; 279(17):948. PubMed ID: 20617606
[No Abstract] [Full Text] [Related]
20. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL
Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
